5-year overall survival | Клиническая онкология


Log in Registration Search for: Home Electronic publication Fresh number Archives Authors About Edition Subscription Requirements for authors Reviewing Editorial board
Organization of anticancer fight Tumors of the chest cavity Tumors of abdominal organs Tumors of skin, soft tissues, bones Breast tumor Oncogynecology Tumors of the head and neck Oncurology Oncohematology Radiation diagnostics, radiation therapy Experimental studies Magazine online All news	Keyword : 5-year overall survival Five-year overall survival and progression-free survival of patients with advanced NSCLC receiving pembrolizumab T. 10, № 3-4 (39-40)
MORION Publishing House Editorial office and publisher: 02140, Kyiv, ave. Bazhana 10A Tel.: 380 (44) 585-97-10 Specialized medical online publication for doctors, pharmacists, pharmacists, medical students and pharmaceutical universities.Disclaimer morion.ua apteka.ua pharmstandart.com.ua compendium.com.ua proximaresearch.com

Keyword : 5-year overall survival